Monterey Bio Acquisition Corporation

MTRY

MTRYMonterey Bio Acquisition Corporation US flag

NASDAQ Global Market

11.14

USD

-0.03

(-0.27%)

-0.13EPS

-85.69P/E

48.30MMarket Cap

Mar 31Next Earn

Monterey Bio Acquisition Corporation

MTRY

(NASDAQ Global Market)

Recent

price

11.14

P/E

ratio

-85.6923076923077

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 03/18

Stock

S&P500

8.05

18.57

12.53

40.07

12.53

86.07

No results.

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

No results.

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: 2MX Organic S.A. (2MX.PA)
FinTech Evolution Acquisition Group (FTEV-UN)
Chavant Capital Acquisition Corp. (CLAYW)
Apollo Strategic Growth Capital (APSG)
Kunekt Corporation (KNKT)
RedBall Acquisition Corp. (RBAC-UN)
Business: Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.